TABLE 1.
Baseline clinical characteristics of patients treated with paclitaxel-eluting stents (PES) and those treated with bare metal stents (BMS)
| PES (n=512) | BMS (n=722) | P | |
|---|---|---|---|
| Age, years (mean ± SD) | 63±2 | 65±12 | N/A |
| Female sex, n (%) | 150 (29) | 224 (31) | 0.5 |
| Diabetes, n (%) | 138 (27) | 186 (26) | 0.6 |
| Non-insulin-dependent | 92 (18) | 122 (17) | 0.62 |
| Insulin-dependent | 46 (9) | 64 (9) | 0.9 |
| Hypertension, n (%) | 348 (68) | 505 (70) | 0.5 |
| Current cigarette smoking, n (%) | 115 (22) | 160 (22) | 0.9 |
| Dyslipidemia, n (%) | 390 (76) | 584 (81) | 0.05 |
| Previous myocardial infarction, n (%) | 297 (58) | 488 (68) | 0.001 |
| Previous PTCA, n (%) | 78 (15) | 88 (12) | 0.1 |
| Previous CABG, n (%) | 64 (13) | 83 (12) | 0.6 |
| Multivessel disease, n (%) | 269 (53) | 353 (49) | 0.2 |
| Inpatient referral, n (%) | 272 (53) | 422 (59) | 0.1 |
| Clinical presentation, n (%) | |||
| Stable angina | 205 (40) | 219 (30) | 0.0004 |
| Unstable angina/NSTEMI | 307 (60) | 503 (70) |
CABG Coronary artery bypass grafting; N/A Not applicable; NSTEMI Non-ST segment elevation myocardial infarction; PTCA Percutaneous transluminal coronary angioplasty